SCHEMBL7303801

SCHEMBL7303801

CCCCC(NCC(CC(C)C)NC(=O)c1ccccc1)C(=O)CSCc1ccco1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
POLB P06746 4/20 0.40
HSD17B10 Q99714 2/20 0.40
MAPT P10636 2/20 0.40
USP2 O75604 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CTSL P07711 3/20 0.36
CTSB P07858 2/20 0.36
CTSK P43235 2/20 0.36
CTSS P25774 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
HPGD P15428 3/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
TSHR P16473 1/20 0.35
PRSS1 P07477 1/20 0.35
CTSG P08311 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7299096 0.93 ALDH1A1 (0.43) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7442933 0.93 ALDH1A1 (0.44) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7313603 0.93 ALDH1A1 (0.40) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL8686162 0.91 NPC1 (0.48) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7300826 0.91 TAS1R3 (0.42) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7301737 0.91 SMN1; SMN2 (0.44) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7310588 0.90 HPGD (0.41) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7306338 0.90 ALDH1A1 (0.38) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7300617 0.89 ALDH1A1 (0.37) ALDH1A1POLBHSD17B10MAPTUSP2
SCHEMBL7305075 0.89 CYP1A2 (0.42) ALDH1A1POLBHSD17B10MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0525420-B1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors MITSUBISHI CHEM CORP (JP) 1999-05-12 EP disclosed
US-5834508-A PROTEASE ENZYME INHIBITORS; MUSCLE DISORDERS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-11-10 US disclosed
US-5639783-A POTENT PROTEASE INHIBITOR FOR TREATING MUSCULAR, NERVOUS SYSTEM DISEASES MITSUBISHI CHEMICAL CORPORATION (JP) 1997-06-17 US disclosed
EP-0525420-A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors Mitsubishi Chemical Corporation (JP) 1993-02-03 EP disclosed